Home532989 • BOM
add
Bafna Pharmaceuticals Ltd
Previous close
₹81.29
Day range
₹81.00 - ₹81.16
Year range
₹73.35 - ₹112.20
Market cap
1.89B INR
Avg Volume
357.00
P/E ratio
460.46
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 403.23M | -0.87% |
Operating expense | 103.50M | 13.47% |
Net income | 26.17M | 5.37% |
Net profit margin | 6.49 | 6.22% |
Earnings per share | — | — |
EBITDA | 37.27M | -6.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.15M | -83.28% |
Total assets | 1.34B | -0.53% |
Total liabilities | 514.09M | -2.09% |
Total equity | 827.51M | — |
Shares outstanding | 23.58M | — |
Price to book | 2.32 | — |
Return on assets | — | — |
Return on capital | 5.36% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 26.17M | 5.37% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
363
